Patrycja Wójcicka

Patrycja Wójcicka

Auto-generated profile, based on publicly available information

Patrycja Wójcicka

Chair and Department of Medical Microbiology, Medical University, 20-059 Lublin, Poland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2023 in Environmental Medicine
Verified
Journal Article
Open access
MWMonika Wałęka
Monika Wałęka
PWPatrycja Wójcicka
Patrycja Wójcicka
DŻDorota Żakowska
Dorota Żakowska
Introduction and objective: The A. albopictus mosquito, commonly known as the Asian tiger mosquito, is a vector of many infectious diseases that have been transferred from south-east Asia to many European countries. For this reason, the monitoring of this species in Europe is necessary to...

29 December 2021 in Annals of Agricultural and Environmental Medicine
Verified
Journal Article
Open access
AMAleksander Michalski
Aleksander Michalski
PWPatrycja Wójcicka
Patrycja Wójcicka
ABAgata Bielawska-Drózd
Agata Bielawska-Drózd
MBMichał Bartoszcze
Michał Bartoszcze
Introduction and objective: COVID-19 is a human infectious disease manifested by acute respiratory syndrome. On 30 January, 2020, the Word Heath Organization (WHO) declared a COVID-19 pandemic. The purpose of this article is to review publications on the search for substances that show...

30 October 2025 in Annals of Agricultural and Environmental Medicine
Verified
Journal Article
Open access
DŻDorota Żakowska
Dorota Żakowska
PGPatrycja Głowacka
Patrycja Głowacka
PWPatrycja Wójcicka
Patrycja Wójcicka
IBIzabela Marczuk Bany
Izabela Marczuk Bany
MOMonika Ogórkiewicz
Monika Ogórkiewicz
MCMarta Ciesielska
Marta Ciesielska
Introduction and objective: Brucella and Ochrobactrum are genetically-related strains of bacteria belonging to the same Alphaproteobacteria class, due to their evolutionary origin. However, the two strains are distinct species. Brucella is the genus of bacteria that causes the infectious...

16 December 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
PGPatrycja Głowacka
Patrycja Głowacka
IBIzabela Marczuk Bany
Izabela Marczuk Bany
PWPatrycja Wójcicka
Patrycja Wójcicka
MOMonika Ogórkiewicz
Monika Ogórkiewicz
MCMarta Ciesielska
Marta Ciesielska
BCBeata Cieśluk-Olchowska
Beata Cieśluk-Olchowska
Background: There are many methods of identifying microbial resistance to therapeutic agents; however, they can generally be classified into two main categories: phenotypic and genotypic. The study aims to determine drug sensitivity and to analyze the correlation between the results obtained from cultures on commercial chromogenic media BrillianceTM CRE (OXOID) and BrillianceTM ESBL (OXOID) and the occurrence of specific resistance genes carbapenemase (IMP, NDM, VIM, KPC, OXA), ESBL β-lactamase (TEM, SHV, CTX-M), and AmpC (CMY, DHA), which will be used in drug sensitivity tests. Methods: The present study used bacteria, including Klebsiella pneumoniae, Acinetobacter baumannii, and Escherichia coli, obtained from patients hospitalized in military hospitals in Poland. All strains were plated on the commercial chromogenic media and subjected to antimicrobial susceptibility testing. Additionally, molecular assays detecting three main classes according to the mechanism of action, enzyme type carbapenemase (IMP, NDM, VIM, KPC, OXA), ESBL β-lactamase (TEM, SHV, CTX-M), and AmpC (CMY, DHA) were performed using the real-time PCR method. Results: The results of the studies indicate the presence of carbapenemases and ESBL genes. Among K. pneumoniae strains, the dominant gene was CTX-M-15 (88.89%), followed by the SHV (84.12%), NDM (46.03%), TEM (41.26%), KPC (34.92%), and OXA-48 (19.04%). In contrast, A. baumanii was dominated by carbapenemases from the OXA family (OXA-51 in 96.00% and OXA-24/40 in 84.00%). E. coli exhibits a high prevalence of CTX-M-15 (53.85%), TEM (46.15%), NDM (38.46%), and CMY-2 (30.77%). It was observed that the CTX-M-15 gene was commonly co-identified with SHV (n = 43). All tested strains grew on chromogenic BrillianceTM CRE medium. In the case of BrillianceTM ESBL medium, the genes determining the resistance mechanism were detected in 41.7% for A. baumannii, 53.8% for E. coli, and 100% for K. pneumoniae. Chromogenic media perfectly differentiate strains to species. A moderate positive correlation of the occurrence of the antibiotic resistance genes was observed for OXA-51 and OXA-24/40 genes, which were resistant to meropenem (rho = 0.45, p < 0.001). K-means cluster analysis performed on integrated genotype–phenotype data allowed for the identification of three distinct clusters characterized by distinct resistance gene profiles. These results demonstrate that selective agar media enable faster identification compared to other conventional techniques; however, the obtained results should be confirmed by other validated phenotypic methods, and, if possible, by a molecular assay.